Future combined vaccines

Journal of Infectious Diseases

Volumn 174, Issue SUPPL. 3, 1996, Pages

  Bégué, Pierre ^a   Grimprel, Emmanuel ^a  

^a ARMAND TROUSSEAU HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS HAEMOPHILUS INFLUENZAE TYPE B VACCINE; MEASLES MUMPS RUBELLA VACCINE; PERTUSSIS VACCINE; POLIOMYELITIS VACCINE; UNCLASSIFIED DRUG;

ANTIBODY SPECIFICITY; COMBINATION CHEMOTHERAPY; DRUG FORMULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNIZATION; IMMUNOGENICITY; INFANT; INFANT DISEASE; INFECTION PREVENTION; PRESCHOOL CHILD; PRIORITY JOURNAL; REVACCINATION; REVIEW; VACCINATION;

EID: 0029966196     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/174.supplement_3.s295     Document Type: Review

References (11)

1. King GE, Hadler SC. Simultaneous administration of childhood vaccines: an important public health policy that is safe and efficacious. Pediatr Infect Dis J 1994; 13:394-407.
2. Edwards KM, Decker MD. Combination vaccines: hopes and challenges. Pediatr Infect Dis J 1994; 13:345-7.
3. American Academy of Pediatrics. Committee on Infectious Diseases. Acellular pertussis vaccines: recommendations for use as the fourth and fifth doses. Pediatrics 1992; 1:121-3.
4. International Symposium on Pertussis Vaccine Trials, Rome October 30-November 1, 1995: trial synopses. Rome: Instituto Superiore di Sanita, 1995.
5. Gustafsson L, Hallander HO, Olin P, Reizenstein E, Storsaeter J. A controlled trial of a-two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine. N Engl J Med 1996; 334:349-55.
6. Trollfors B, Taranger J, Lagergard T, et al. A placebo-controlled trial of a pertussis-toxoid vaccine. N Engl J Med 1995;333:1045-50.
7. Greco D, Salmaso S, Mastrantonio P, et al. A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. N Engl J Med 1996;334:341-8.
8. Avendano A, Ferreccio C, Lagos R, et al. Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine does not depress serologic responses to diphtheria-tetanus or pertussis antigens when coadministered in the same syringe with diphtheria-tetanus-pertussis vaccine at two, four or six months of age. Pediatr Infect Dis J 1993; 12:638-43.
9. Ferreccio C, Clemens J, Avendano A, et al. The clinical and immunologic response of Chilean infants to Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine coadministered in the same syringe with diphtheria-tetanus toxoids-pertussis vaccine at two, four and six months of age. Pediatr Infect Dis J 1991; 10:764-71.
10. Watemberg N, Dagan R, Arbelli Y, et al. Safety and immunogenicity of Haemophilus type b-tetanus protein conjugate vaccine, mixed in the same syringe with diphtheria-tetanus-pertussis vaccine in young infants. Pediatr Infect Dis J 1991; 10:758-61.
11. Edwards KM. Acellular pertussis vaccines - a solution to the pertussis problem? J Infect Dis 1993; 168:15-20.